RTB101

Drug / Medication

A catalytic inhibitor of mTOR complex 1, studied for its immune-enhancing benefits, particularly in reducing respiratory tract infections. It is an ATP-competitive inhibitor.

Mentioned in 1 video

Videos Mentioning RTB101

#123–Joan Mannick & Nir Barzilai: Rapamycin and metformin—longevity, immune enhancement, & COVID-19

#123–Joan Mannick & Nir Barzilai: Rapamycin and metformin—longevity, immune enhancement, & COVID-19

Peter Attia MD

A catalytic inhibitor of mTOR complex 1, studied for its immune-enhancing benefits, particularly in reducing respiratory tract infections. It is an ATP-competitive inhibitor.